News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ethics Committee Investigating New York Congressman's Ties to This Australian Biotech



5/18/2017 6:18:52 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Rep. Chris Collins, R-N.Y., faces an investigation from the independent Office of Congressional Ethics for his part in attracting investors to an Australian biotech company.

Collins is Innate Immunotherapuetics's largest shareholding, his stakes worth between $5 and $25 million, and boasted earlier this year about "how many millionaires I've made in Buffalo the past few months," according to The Buffalo News.

Anonymous sources told Buffalo News that investigators have interviewed several investors in the Buffalo area about Collin's role in persuading them to buy the company's stock.

Read at News Release
Read at News Release
Read at Buffalo News


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES